Incannex Healthcare Inc. (IXHL)
NASDAQ: IXHL · Real-Time Price · USD
0.2100
-0.0100 (-4.55%)
At close: May 30, 2025, 4:00 PM
0.1910
-0.0190 (-9.05%)
After-hours: May 30, 2025, 7:59 PM EDT
Incannex Healthcare Revenue
Incannex Healthcare had revenue of $98.00K in the twelve months ending March 31, 2025. In the fiscal year ending June 30, 2024, Incannex Healthcare had annual revenue of $12.00K.
Revenue (ttm)
$98.00K
Revenue Growth
n/a
P/S Ratio
38.44
Revenue / Employee
$10,889
Employees
9
Market Cap
19.68M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
IXHL News
- 2 days ago - Incannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol Clearance - GlobeNewsWire
- 3 days ago - Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025 - Newsfile Corp
- 3 days ago - Incannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline Results - GlobeNewsWire
- 11 days ago - Incannex Healthcare Inc. Executes Strategic Cancellation of 50.4% of Series A Warrants, Significantly Reducing Potential Dilution - GlobeNewsWire
- 15 days ago - Incannex Announces Potential Reduction of Up to 50.4% of its Series A Warrants - GlobeNewsWire
- 16 days ago - Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates - GlobeNewsWire
- 17 days ago - Incannex Healthcare (IXHL) Stock Soars Over 800%: What's Going On? - Benzinga
- 17 days ago - Incannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA) - GlobeNewsWire